Understanding the Reasons and Issues for Low NMOSD Activity Rates: Farrah Mateen, MD, PhD

Published Date: 02 Mar 2023

Understanding the Reasons and Issues for Low NMOSD Activity Rates: Farrah Mateen, MD, PhD

Read Full News

Latest News

Sleep Disorders May Raise Risk for Sudden Death in Epilepsy

Comorbid primary sleep disorders are tied to higher risk for sudden unexpected death, all-cause mortality, and accidents in patients with epilepsy, a new study finds.

Transcranial Stimulation Shows Promise for Teen Self-Injury

For adolescents with depression and nonsuicidal self-injury, high-intensity transcranial alternating current stimulation improved emotion regulation, reduced attention to self-injury cues, and eased depressive symptoms in a proof-of-concept trial.

Can Treating Prodromal MS Delay or Prevent Disease Onset?

Researchers are investigating whether treating prodromal symptoms that precede radiologically isolated syndrome can delay or prevent disease onset.

Difficulty Conceiving, Not IVF, Linked to Autism Risk

The findings highlight the need to better understand the causes of infertility rather than the treatments used to address it.

New Fall-Detection Tech Could Ease Nursing Workloads

AI-powered radar systems may alert staff before a fall happens, with early studies showing fewer falls and less strain on nursing teams.

Popular Joint Supplement Tied to Faster AD Progression

A new study links glucosamine use to faster progression from MCI to dementia and identifies glycan metabolism as a potential new therapeutic target in Alzheimer’s disease.

Todays Updates

FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug

The U.S. Food and Drug Administration has declined to approve Achieve Life Sciences' drug to treat nicotine dependence in adults, ⁠citing unresolved issues found at a...

The New Perfectionism Problem in Medical Training

The profession has always attracted perfectionists. Experts worry a more fear-based version of the trait could affect both doctors and patients.

Rucaparib Delays Next Lines of Therapy in Ovarian Cancer

Rucaparib maintenance delays both first and second subsequent therapies among patients with advanced ovarian cancer.

Todays Updates

FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug

The U.S. Food and Drug Administration has declined to approve Achieve Life Sciences' drug to treat nicotine dependence in adults, ⁠citing unresolved issues found at a...

The New Perfectionism Problem in Medical Training

The profession has always attracted perfectionists. Experts worry a more fear-based version of the trait could affect both doctors and patients.

Rucaparib Delays Next Lines of Therapy in Ovarian Cancer

Rucaparib maintenance delays both first and second subsequent therapies among patients with advanced ovarian cancer.

Latest News

Comorbid primary sleep disorders are tied to higher risk for sudden unexpected death, all-cause mortality, and accidents in patients with epilepsy, a new study finds.

For adolescents with depression and nonsuicidal self-injury, high-intensity transcranial alternating current stimulation improved emotion regulation, reduced attention to self-injury cues, and eased depressive symptoms in a proof-of-concept trial.

Researchers are investigating whether treating prodromal symptoms that precede radiologically isolated syndrome can delay or prevent disease onset.

The findings highlight the need to better understand the causes of infertility rather than the treatments used to address it.

AI-powered radar systems may alert staff before a fall happens, with early studies showing fewer falls and less strain on nursing teams.

A new study links glucosamine use to faster progression from MCI to dementia and identifies glycan metabolism as a potential new therapeutic target in Alzheimer’s disease.

News All Time

Federally Funded Research Backs Tighter Drinking Limits

A federally funded review conducted to inform US dietary advice supports a one-drink-per-day limit for all adults — a stricter recommendation than current federal guidance.

Melatonin Gummies Blur Line Between Medicine and Candy

Pediatricians call for a ban on melatonin gummy bears and similar products, warning that candy-like supplements may encourage unsupervised use in children.

A New Option for Headache?

Findings come from a single-center study suggest the non-opioid suzetrigine may help reduce pain in multiple headache types, but more research is needed.

NfL a Biomarker for Cognitive Function in Patients With MS?

New data offer strong evidence that neurofilament light chain (NfL) levels could be an accurate biomarker for monitoring cognitive function in MS.

Most ‘Sleep-Divorced’ Couples Support Sleeping Separately

A study in Brazil reveals the prevalence and attitudes among couples not driven by relationship stress toward ‘sleep divorce’ arrangements.

Experimental Drug Cuts Migraine Days in Mid-stage Trial

Denmark's Lundbeck said on Thursday its experimental drug bocunebart cut monthly migraine days in ⁠a mid-stage study, supporting further development of a new type of...

Spinal Cord Treatment Triggers Hope and Lawsuits in Brazil

An experimental treatment for spinal cord injuries is drawing patients from as far as Mexico, mobilizing the government to expedite approval before its safety has been proven in a clinical trial.

Global Lewy Body Dementia Incidence: New Data

The first known analysis of pooled worldwide population-based data on dementia with Lewy bodies shows incidence is higher than that of other uncommon neurological disorders.

Comorbid Illness Common in Functional Neurologic Disorder

Functional neurologic disorder has a higher mortality rate than multiple sclerosis and often occurs with comorbid neurologic and psychiatric disorders, a new study shows.

First Clear Win for BTK Inhibitors in Relapsing MS

After previous disappointments with BTK inhibitors, a novel drug in this class is the first to show superiority to an active comparator for relapsing MS outcomes.

Primary Care Making More Mental Health Diagnoses for Kids

Pediatric mental health visits in primary care surged over a 9-year period.

Electroacupuncture Promising for Cognitive Improvement in AD

Electroacupuncture was associated with long-term efficacy in improving cognitive function compared to sham treatment in patients with Alzheimer’s disease, a new trial shows.

Coffee Linked to Better Cognition in Patients With PD

Coffee consumption is associated with improved executive function in patients with early Parkinson’s disease, while smoking has no impact, a new study suggests.

Undiagnosed Dementia Tied to Increased Mortality Risk

Undiagnosed dementia is highly prevalent in the US and Brazil and is linked to increased 4-year mortality in both countries, a large cohort study shows.

How One Psilocybin Trip May Reshape the Brain

New research suggests a single high dose of psilocybin alters neural activity and may trigger lasting structural brain changes tied to improved well-being.

Brain Cooling Boosts LVO Recovery After Thrombectomy

Targeted intra-arterial cooling delivered during clot retrieval significantly increases functional independence after large-vessel ischemic stroke, with no added risk.

Recommended News For You

For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.

Dietary Intervention Shows Promise in Blood Cancers

Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement

Investigating the Relationship Between GERD and Anxiety/Depression.

Trump Issues Gag Order for CDC, FDA; Stalled Hearing for RFK Jr.; Sex After Cancer

Alkem introduces cetuximab under the trade name Cetuxa in India.

Recommended Articles For You

Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer 

Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy 

Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked 

Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.

2.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

3.

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

4.

'Ray of hope': New developments in the fight against various cancers.

5.

After HSCT, a longer course of letermovir prophylaxis decreased the risk of cytomegalovirus infection.

1.

Contemporary Pathways in Hematology and Patient Outcomes

2.

Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review

3.

Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment

4.

Decoding the Future: Cancer Genomics and Radiomics in Oncology

5.

Understanding Granulosa Cell Tumors: Symptoms, Diagnosis, and Treatments"

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

3.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

5.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot